2252-1567 Screening compound: N-(1,3-benzothiazol-2-yl)-4-cyclohexaneamidobenzamide

2252-1567 Screening compound: N-(1,3-benzothiazol-2-yl)-4-cyclohexaneamidobenzamide
2252-1567 Screening compound: N-(1,3-benzothiazol-2-yl)-4-cyclohexaneamidobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2252-1567
N-(1,3-benzothiazol-2-yl)-4-cyclohexaneamidobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2252-1567

Molecular Formula

C21H21N3O2S (C21 H21 N3 O2 S)

Compound Name

N-(1,3-benzothiazol-2-yl)-4-cyclohexaneamidobenzamide

IUPAC name

N-(13-benzothiazol-2-yl)-4-cyclohexaneamidobenzamide

SMILES

O=C(C1CCCCC1)Nc(cc1)ccc1C(Nc1nc(cccc2)c2s1)=O

InChI

InChI=1S/C21H21N3O2S/c25-19(14-6-2-1-3-7-14)22-16-12-10-15(11-13-16)20(26)24-21-23-17-8-4-5-9-18(17)27-21/h4-5,8-14H,1-3,6-7H2,(H,22,25)(H,23,24,26)

InChI Key

BXHIIXFLBAITDZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01596302

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

379.48

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.825

Distribution Coefficient, logD

4.822

Water Solubility, LogSw

-4.77

Polar Surface Area

56.374

Acid Dissociation Constant (pKa)

9.62

Base Dissociation Constant (pKb)

-0.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

2252-1567 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Angiogenesis library (14822 compounds)

Antiviral Library (67538 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with 2252-1567 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2252-1567?
Check Price and Availability of 2252-1567, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2252-1567 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2252-1567
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2252-1567
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2252-1567 available by request